Filters
Documents
Showing 25 of 659 items meeting your criteria.
| Type | Category | Supplier | ||
|---|---|---|---|---|
 | Necroptosis, a form of regulated cell death, has gained significant attention recently due to its involvement in various physiological and pathological processes. Necroptosis is a specialized form of programmed cell death that is tightly controlled by various signaling pathways, mediators, and immune responses. Interferon-γ (IFN-γ) and Toll-like receptor 4 (TLR4) signaling pathways have been identified as critical regulators of necroptosis in macrophages. Understanding the underlying molecular mechanisms that govern necroptosis is essential for unraveling its role in immune responses and disease pathogenesis. | |||
Documents | Antibodies | ProSci | ||
 | Camelid Single Domain Antibodies (sdAbs), also known as nanobodies, have emerged as powerful tools in immunology and molecular biology. CD8A, a vital cell surface glycoprotein in immune responses, has become a focus of research and diagnostics. Derived from camelids, these sdAbs offer advantages such as a small size for precise targeting, stability in extreme conditions, and unique binding capabilities. | |||
Documents | Antibodies | Abnova Corporation | ||
 | Abnova offers Camelid Single Domain Antibody Service for production of target-specific sdAb from naïve camelid VHH library. By using the advanced naïve camelid VHH library screening technology, they screen the library and isolate the sdAb clones for your required antigens. Positive clones are sequenced and validated by ELISA. The selected clones will then be introduced into HEK293 expression vector or E. coli expression vector for transient and scalable sdAb production for many downstream applications. | |||
Documents | Service | Abnova Corporation | ||
 | Abnova camelid single domain antibodies (sdAbs) derived from alpacas or llamas with great penetrability and affinity to recognize difficult epitopes. The product lines include FluoTag-Q, FluoTag-X2 and FluoTag-X4, featuring different number of sdAb and coupled fluorophore. In FluoTag-Q series, each fluorophore is conjugated to exactly one sdAb. The FluoTag-X2 series contains two fluorophores coupled with one sdAb. In terms of FluoTag-X4, it is a mix of 2 sdAbs that can bind simultaneously with the target molecule, and each sdAb is coupled with 2 fluorophores. | |||
Documents | Antibodies | Abnova Corporation | ||
 | iXCells provides products to accelerate drug discovery, development and translation for nervous system disorders. | |||
Documents | Neuroscience | iXCells Biotechnologies | ||
 | The term "adjuvant" derives from adjuvare, meaning to assist. Any material that increases the humoral and/or cellular immune response of an antigen is considered as an adjuvant and it is said to be immunogenic. A multitude of adjuvants of extremely diverse origin exist. Two of the most distinguished adjuvant types are the immune-stimulating agents and the "vaccine-carriers". The immune-stimulating agents activate the immune cells directly by binding to different receptors. While the vaccine carriers contain the antigen and are able to incorporate it into the immune system in different manners. However, vehicles often have their own immunostimulatory properties, simply because they constitute foreign bodies. | |||
Documents | Immunology | Oz Biosciences | ||
 | Magnetofection™ was developed to gather, in one convenient system, the advantages of the popular biochemical (cationic lipids or polymers) and physical transfection methods (electroporation, gene gun) while overcoming their respective limitations such as low efficiency, toxicity, and difficulty in handling. Magnetofection can be defined as the delivery of nucleic acids, either naked or packaged (in complexes with lipids or polymers, and viruses), using magnetic nanoparticles (MNP) under the guidance of an external magnetic field. | |||
Documents | Transfection | Oz Biosciences | ||
 | RNA can suffer degradation when not handled, stored, or used properly. In order to assess how stable OZ Biosciences mRNA is, they have tested a randomly chosen RNA from their catalogue, Tomato RNA, and submitted it to several freeze/thaw cycles as well as mid-term storage at room temperature (RT). | |||
Documents | RNA | Oz Biosciences | ||
 | iXCells offers a diverse range of hepatic cell products designed to cater to your specific needs. Whether youre focused on drug metabolism studies, liver disease research, or toxicology assessments, their catalogue of cells is tailored to accelerate your scientific discoveries. | |||
Documents | Primary Cells | iXCells Biotechnologies | ||
 | Abnova provide a range of PEG and Anti-PEG ELISA Kits. | |||
Documents | ELISA | Abnova Corporation | ||
 | Related products for Cytokines - interleukin | |||
Documents | Cytokines | Cloud-Clone Corp. | ||
 | Some researchers require a product which is serum-free and has had no contact with human or animal cells. We have, therefore, designed BriClone-SF which has the same basal medium and biological activities as BriClone but has no added serum or other substances of human or animal origin and has not been exposed to cells. BriClone-SF contains added recombinant human proteins produced in bacterial or yeast host cells. | |||
Documents | Cell Culture | NICB | ||
 | Protocol for Use for BriClone-SF Hybridoma Cloning Supplement | |||
Documents | Cell Culture | NICB | ||
 | Material Safety Data Sheet for BriClone-SF Hybridoma Cloning Supplement | |||
Documents | Cell Culture | NICB | ||
 | BriClone is added to Hybridoma culture media as a 5% v/v supplement to replace the time-consuming task of preparing feeder cells during routine cloning of hybridomas. | |||
Documents | Cell Culture | NICB | ||
 | BriClone has been cited in many publications over the years, and in a range of research areas. | |||
Documents | Cell Culture | NICB | ||
 | NICB has over 25 years of experience in antibody development & developed BriClone, a supplement for improving fusion efficiency and supporting cloning outgrowth of hybridoma cells at those fragile early steps. | |||
Documents | Cell Culture | NICB | ||
 | In 2005, researchers in Graduate School of Dentistry and Dept. of Oral Pathology at Osaka Dental University (Japan) were seeking to develop novel agents for use in periodontal regeneration therapy. The researchers published two studies utilising hybridoma technology to successfully produce monoclonal antibodies (mAbs) against the rat periodontium (RPT1) and the human cemento-periodontal ligament junction (anti-TAP). | |||
Documents | Cell Culture | NICB | ||
 | An overview of the research applications of BriClone Hybridoma Cloning and Selection Supplement. | |||
Documents | Cell Culture | NICB | ||
 | BriClone has been manufactured onsite for over 25 years by research scientists at the publicly-funded National Institute for Cellular Biotechnology, (Dublin City University, Dublin, Ireland) and has a long history of application in research internationally. | |||
Documents | Cell Culture | NICB | ||
 | BriClone is an additive for the cloning medium used in the post-fusion stages of hybridoma production and for improving the efficiency of hybridoma cells cloning.
To demonstrate the stability of BriClone, various simulated conditions were assessed mimicking different temperature exposures.
Post-fusion hybridoma production was assessed using BriClone under different conditions (overnight at room temperature) as a positive control, as well as one week stored at 4°C. | |||
Documents | Cell Culture | NICB | ||
 | BriClone is an additive for the cloning medium used in the post-fusion stages of hybridoma production and for improving the efficiency of hybridoma cells cloning.
Many commercial additives are available for improving the improving the efficiency of cell cloning at the post-fusion stages of hybridoma production. In the following experiment, BriClone was compared to two competitors as a supplement for post-fusion hybridoma production by assessing fusion efficiency. | |||
Documents | Cell Culture | NICB | ||
 | BriClone is an additive for the cloning medium used in the post-fusion stages of hybridoma production and for improving the efficiency of hybridoma cells cloning.
The use of feeder cells to support the outgrowth of hybridomas has many disadvantages, like batch-to-batch variation of the feeder cells and competition between feeder cells and freshly-fused hybridomas for nutrients in the culture medium. BriClone has been specially developed to overcome these common problems in the post-fusion period. | |||
Documents | Cell Culture | NICB | ||
 | Protocol for Use for BriClone Hybridoma Cloning Supplement | |||
Documents | Cell Culture | NICB | ||
 | Material Safety Data Sheet for BriClone Hybridoma Cloning Supplement | |||
Documents | Cell Culture | NICB | ||